April 14-19, 2023 | Orange County Convention Center | Orlando, FL

aacr 2023 with Sapient

Sapient is excited to join the cancer research community for this prestigious event which will facilitate important discussions to advance cancer treatment, prevention, and cures.

If you’ve been wanting to learn more about discovery metabolomics and the applications of small molecule biomarkers in your oncology programs – from target identification to immunotherapy safety profiling to enriching cancer clinical trials – then we invite you to meet up with our team during AACR in the following ways:

Visit us at Bruker’s Booth #1818

Bruker is a valued partner to Sapient and has invited us to join their booth space this year. Stop by to see Bruker’s latest bioanalytical and diagnostic innovations and to meet with Sapient’s attending team members, including Dr. Tanya Nguyen, Head of Scientific Operations, and Dr. Phil Worboys, Head of Translational Science. You can learn how we leverage Bruker’s timsTOF Pro 2 systems as part of our rLC-MS platform to enable high-throughput, nontargeted biomarker discovery across broad chemistries.

Pre-schedule an on-site meeting

Have specific questions or potential programs you’d like to discuss? We would love to talk through your needs and how we can partner together to accelerate your drug discovery and development efforts. Use this link to preschedule a 1-on-1 meeting time during AACR.

Join us at AACR 2023

April 14-19, 2023 | Orange County Convention Center | Orlando, FL Sapient is excited to join the cancer research community for this prestigious event which will facilitate important discussions to advance cancer treatment, prevention, and cures. If… Read More

Sapient Featured as Collaborator in Cedars-Sinai Study on Immune Responses and COVID-19

Study infrastructure and biospecimen processing support is being provided by Sapient for the study, which is focused on advancing vital immune response research for COVID-19 and other autoimmune and inflammation-associated diseases. Cedars-Sinai’s press release highlights key study findings now published in JAMA Network Open on COVID-19 infection awareness rates, indicating… Read More

Philip Worboys, Ph.D. Joins Sapient as Head of Translational Science

San Diego, CA—Sapient, a full-service bioanalytical research organization transforming the efficiency of biomarker discovery for pharmaceutical and biotechnology sponsors, announced that Philip Worboys, Ph.D. has joined its leadership team as Head of Translational Science. In this role, Dr. Worboys will work with Sapient’s cross-functional teams to develop and execute scientifically… Read More